Health
First Randomized Trial Reassures on ACEIs, ARBs in COVID-19 – Medscape
The BRACE CORONA study found no difference in key outcomes between patients continuing vs stopping their medication.
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center.
The first randomized study to compare continuing vs stopping angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) for patients with COVID-19 has shown no difference in key outcomes between the two approaches.
The BRACE CORONA trial conducted in patients had been taking an ACE inhibitor or an ARB on a long-term basis and who were subsequently hospitalized with C…
-
Noosa News18 hours agoYoung voices shape Sunshine Coast’s future
-
Business17 hours ago2 Low Cost Active ASX ETFs to consider
-
Noosa News17 hours agoQueensland government to review greenhouse gas emission reduction targets
-
Noosa News14 hours agoCopperString transmission line projected to cost almost $14b amid massive blowout